In the Ctrl group, 18.8% percent of the tumor contained >50 CD8+ cells per microscopic field compared to 6.6%, 2.9% and 0.0% respectively for groups that received neutralizing antibodies to IL-18, IFN-γ, or both (Fig. 2 B, Fig. 3 A & B). Here, IL18 is linked to neoplasm.